[{"Assets_0_FY_USD":631679000.0,"CommonStockSharesConverted_0_FY_shares":123658287.0,"CommonStockSharesOutstanding_0_FY_shares":123658287.0,"EarningsPerShareBasic_4_FY_USD":-2.48,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-253587000.0,"StockholdersEquity_0_FY_USD":408454000.0,"StockholdersEquityConverted_0_FY_USD":473733000.0,"NetIncomeLossConverted_4_FY_USD":-260587000.0,"RevenuesConverted_4_FY_USD":40560000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200303"}]